Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

Global GP Vaccination Market Growth 2022-2028

  • LP 4940006
  • 115 Pages
  • March 2022
  • Pharmaceuticals
Download Sample    Get Discount   
 
As the global economy mends, the 2021 growth of GP Vaccination will have significant change from previous year. According to our (LP Information) latest study, the global GP Vaccination market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global GP Vaccination market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States GP Vaccination market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global GP Vaccination market, reaching US$ million by the year 2028. As for the Europe GP Vaccination landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main GP Vaccination players cover Moderna, CanSino Biologicals, Inovio Pharmaceuticals, and Shenzhen Geno-Immune Medical Institute, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of GP Vaccination market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6

DNA

Non-replicating Viral Vector

Protein Subunit

RNA

Others

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.

Adults

Children

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.

Americas

United States

Canada

Mexico

Brazil

APAC

China

Japan

Korea

Southeast Asia

India

Australia

Europe

Germany

France

UK

Italy

Russia

Middle East & Africa

Egypt

South Africa

Israel

Turkey

GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include

Moderna

CanSino Biologicals

Inovio Pharmaceuticals

Shenzhen Geno-Immune Medical Institute

GlaxoSmithKine

Pfizer

Johnson&Johnson

Heat Biologics

Sanofi

Takis Biotech

Zydus Cadila

Codagenix

GeoVax

Bravovax

Altimmune

Vaxart

Clover Biopharmaceuticals

ImmunoPrecise

1 Scope of the Report

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global GP Vaccination Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for GP Vaccination by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for GP Vaccination by Country/Region, 2017, 2022 & 2028

2.2 GP Vaccination Segment by Type

2.2.1 DNA

2.2.2 Non-replicating Viral Vector

2.2.3 Protein Subunit

2.2.4 RNA

2.2.5 Others

2.3 GP Vaccination Sales by Type

2.3.1 Global GP Vaccination Sales Market Share by Type (2017-2022)

2.3.2 Global GP Vaccination Revenue and Market Share by Type (2017-2022)

2.3.3 Global GP Vaccination Sale Price by Type (2017-2022)

2.4 GP Vaccination Segment by Application

2.4.1 Adults

2.4.2 Children

2.5 GP Vaccination Sales by Application

2.5.1 Global GP Vaccination Sale Market Share by Application (2017-2022)

2.5.2 Global GP Vaccination Revenue and Market Share by Application (2017-2022)

2.5.3 Global GP Vaccination Sale Price by Application (2017-2022)

3 Global GP Vaccination by Company

3.1 Global GP Vaccination Breakdown Data by Company

3.1.1 Global GP Vaccination Annual Sales by Company (2020-2022)

3.1.2 Global GP Vaccination Sales Market Share by Company (2020-2022)

3.2 Global GP Vaccination Annual Revenue by Company (2020-2022)

3.2.1 Global GP Vaccination Revenue by Company (2020-2022)

3.2.2 Global GP Vaccination Revenue Market Share by Company (2020-2022)

3.3 Global GP Vaccination Sale Price by Company

3.4 Key Manufacturers GP Vaccination Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers GP Vaccination Product Location Distribution

3.4.2 Players GP Vaccination Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for GP Vaccination by Geographic Region

4.1 World Historic GP Vaccination Market Size by Geographic Region (2017-2022)

4.1.1 Global GP Vaccination Annual Sales by Geographic Region (2017-2022)

4.1.2 Global GP Vaccination Annual Revenue by Geographic Region

4.2 World Historic GP Vaccination Market Size by Country/Region (2017-2022)

4.2.1 Global GP Vaccination Annual Sales by Country/Region (2017-2022)

4.2.2 Global GP Vaccination Annual Revenue by Country/Region

4.3 Americas GP Vaccination Sales Growth

4.4 APAC GP Vaccination Sales Growth

4.5 Europe GP Vaccination Sales Growth

4.6 Middle East & Africa GP Vaccination Sales Growth

5 Americas

5.1 Americas GP Vaccination Sales by Country

5.1.1 Americas GP Vaccination Sales by Country (2017-2022)

5.1.2 Americas GP Vaccination Revenue by Country (2017-2022)

5.2 Americas GP Vaccination Sales by Type

5.3 Americas GP Vaccination Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC GP Vaccination Sales by Region

6.1.1 APAC GP Vaccination Sales by Region (2017-2022)

6.1.2 APAC GP Vaccination Revenue by Region (2017-2022)

6.2 APAC GP Vaccination Sales by Type

6.3 APAC GP Vaccination Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe GP Vaccination by Country

7.1.1 Europe GP Vaccination Sales by Country (2017-2022)

7.1.2 Europe GP Vaccination Revenue by Country (2017-2022)

7.2 Europe GP Vaccination Sales by Type

7.3 Europe GP Vaccination Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa GP Vaccination by Country

8.1.1 Middle East & Africa GP Vaccination Sales by Country (2017-2022)

8.1.2 Middle East & Africa GP Vaccination Revenue by Country (2017-2022)

8.2 Middle East & Africa GP Vaccination Sales by Type

8.3 Middle East & Africa GP Vaccination Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of GP Vaccination

10.3 Manufacturing Process Analysis of GP Vaccination

10.4 Industry Chain Structure of GP Vaccination

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 GP Vaccination Distributors

11.3 GP Vaccination Customer

12 World Forecast Review for GP Vaccination by Geographic Region

12.1 Global GP Vaccination Market Size Forecast by Region

12.1.1 Global GP Vaccination Forecast by Region (2023-2028)

12.1.2 Global GP Vaccination Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global GP Vaccination Forecast by Type

12.7 Global GP Vaccination Forecast by Application

13 Key Players Analysis

13.1 Moderna

13.1.1 Moderna Company Information

13.1.2 Moderna GP Vaccination Product Offered

13.1.3 Moderna GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Moderna Main Business Overview

13.1.5 Moderna Latest Developments

13.2 CanSino Biologicals

13.2.1 CanSino Biologicals Company Information

13.2.2 CanSino Biologicals GP Vaccination Product Offered

13.2.3 CanSino Biologicals GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 CanSino Biologicals Main Business Overview

13.2.5 CanSino Biologicals Latest Developments

13.3 Inovio Pharmaceuticals

13.3.1 Inovio Pharmaceuticals Company Information

13.3.2 Inovio Pharmaceuticals GP Vaccination Product Offered

13.3.3 Inovio Pharmaceuticals GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Inovio Pharmaceuticals Main Business Overview

13.3.5 Inovio Pharmaceuticals Latest Developments

13.4 Shenzhen Geno-Immune Medical Institute

13.4.1 Shenzhen Geno-Immune Medical Institute Company Information

13.4.2 Shenzhen Geno-Immune Medical Institute GP Vaccination Product Offered

13.4.3 Shenzhen Geno-Immune Medical Institute GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.4.4 Shenzhen Geno-Immune Medical Institute Main Business Overview

13.4.5 Shenzhen Geno-Immune Medical Institute Latest Developments

13.5 GlaxoSmithKine

13.5.1 GlaxoSmithKine Company Information

13.5.2 GlaxoSmithKine GP Vaccination Product Offered

13.5.3 GlaxoSmithKine GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.5.4 GlaxoSmithKine Main Business Overview

13.5.5 GlaxoSmithKine Latest Developments

13.6 Pfizer

13.6.1 Pfizer Company Information

13.6.2 Pfizer GP Vaccination Product Offered

13.6.3 Pfizer GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.6.4 Pfizer Main Business Overview

13.6.5 Pfizer Latest Developments

13.7 Johnson&Johnson

13.7.1 Johnson&Johnson Company Information

13.7.2 Johnson&Johnson GP Vaccination Product Offered

13.7.3 Johnson&Johnson GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.7.4 Johnson&Johnson Main Business Overview

13.7.5 Johnson&Johnson Latest Developments

13.8 Heat Biologics

13.8.1 Heat Biologics Company Information

13.8.2 Heat Biologics GP Vaccination Product Offered

13.8.3 Heat Biologics GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.8.4 Heat Biologics Main Business Overview

13.8.5 Heat Biologics Latest Developments

13.9 Sanofi

13.9.1 Sanofi Company Information

13.9.2 Sanofi GP Vaccination Product Offered

13.9.3 Sanofi GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.9.4 Sanofi Main Business Overview

13.9.5 Sanofi Latest Developments

13.10 Takis Biotech

13.10.1 Takis Biotech Company Information

13.10.2 Takis Biotech GP Vaccination Product Offered

13.10.3 Takis Biotech GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.10.4 Takis Biotech Main Business Overview

13.10.5 Takis Biotech Latest Developments

13.11 Zydus Cadila

13.11.1 Zydus Cadila Company Information

13.11.2 Zydus Cadila GP Vaccination Product Offered

13.11.3 Zydus Cadila GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.11.4 Zydus Cadila Main Business Overview

13.11.5 Zydus Cadila Latest Developments

13.12 Codagenix

13.12.1 Codagenix Company Information

13.12.2 Codagenix GP Vaccination Product Offered

13.12.3 Codagenix GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.12.4 Codagenix Main Business Overview

13.12.5 Codagenix Latest Developments

13.13 GeoVax

13.13.1 GeoVax Company Information

13.13.2 GeoVax GP Vaccination Product Offered

13.13.3 GeoVax GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.13.4 GeoVax Main Business Overview

13.13.5 GeoVax Latest Developments

13.14 Bravovax

13.14.1 Bravovax Company Information

13.14.2 Bravovax GP Vaccination Product Offered

13.14.3 Bravovax GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.14.4 Bravovax Main Business Overview

13.14.5 Bravovax Latest Developments

13.15 Altimmune

13.15.1 Altimmune Company Information

13.15.2 Altimmune GP Vaccination Product Offered

13.15.3 Altimmune GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.15.4 Altimmune Main Business Overview

13.15.5 Altimmune Latest Developments

13.16 Vaxart

13.16.1 Vaxart Company Information

13.16.2 Vaxart GP Vaccination Product Offered

13.16.3 Vaxart GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.16.4 Vaxart Main Business Overview

13.16.5 Vaxart Latest Developments

13.17 Clover Biopharmaceuticals

13.17.1 Clover Biopharmaceuticals Company Information

13.17.2 Clover Biopharmaceuticals GP Vaccination Product Offered

13.17.3 Clover Biopharmaceuticals GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.17.4 Clover Biopharmaceuticals Main Business Overview

13.17.5 Clover Biopharmaceuticals Latest Developments

13.18 ImmunoPrecise

13.18.1 ImmunoPrecise Company Information

13.18.2 ImmunoPrecise GP Vaccination Product Offered

13.18.3 ImmunoPrecise GP Vaccination Sales, Revenue, Price and Gross Margin (2020-2022)

13.18.4 ImmunoPrecise Main Business Overview

13.18.5 ImmunoPrecise Latest Developments

14 Research Findings and Conclusion

List of Tables

Table 1. GP Vaccination Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. GP Vaccination Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of DNA

Table 4. Major Players of Non-replicating Viral Vector

Table 5. Major Players of Protein Subunit

Table 6. Major Players of RNA

Table 7. Major Players of Others

Table 8. Global GP Vaccination Sales by Type (2017-2022) & (K Units)

Table 9. Global GP Vaccination Sales Market Share by Type (2017-2022)

Table 10. Global GP Vaccination Revenue by Type (2017-2022) & ($ million)

Table 11. Global GP Vaccination Revenue Market Share by Type (2017-2022)

Table 12. Global GP Vaccination Sale Price by Type (2017-2022) & (US$/Unit)

Table 13. Global GP Vaccination Sales by Application (2017-2022) & (K Units)

Table 14. Global GP Vaccination Sales Market Share by Application (2017-2022)

Table 15. Global GP Vaccination Revenue by Application (2017-2022)

Table 16. Global GP Vaccination Revenue Market Share by Application (2017-2022)

Table 17. Global GP Vaccination Sale Price by Application (2017-2022) & (US$/Unit)

Table 18. Global GP Vaccination Sales by Company (2020-2022) & (K Units)

Table 19. Global GP Vaccination Sales Market Share by Company (2020-2022)

Table 20. Global GP Vaccination Revenue by Company (2020-2022) ($ Millions)

Table 21. Global GP Vaccination Revenue Market Share by Company (2020-2022)

Table 22. Global GP Vaccination Sale Price by Company (2020-2022) & (US$/Unit)

Table 23. Key Manufacturers GP Vaccination Producing Area Distribution and Sales Area

Table 24. Players GP Vaccination Products Offered

Table 25. GP Vaccination Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 26. New Products and Potential Entrants

Table 27. Mergers & Acquisitions, Expansion

Table 28. Global GP Vaccination Sales by Geographic Region (2017-2022) & (K Units)

Table 29. Global GP Vaccination Sales Market Share Geographic Region (2017-2022)

Table 30. Global GP Vaccination Revenue by Geographic Region (2017-2022) & ($ millions)

Table 31. Global GP Vaccination Revenue Market Share by Geographic Region (2017-2022)

Table 32. Global GP Vaccination Sales by Country/Region (2017-2022) & (K Units)

Table 33. Global GP Vaccination Sales Market Share by Country/Region (2017-2022)

Table 34. Global GP Vaccination Revenue by Country/Region (2017-2022) & ($ millions)

Table 35. Global GP Vaccination Revenue Market Share by Country/Region (2017-2022)

Table 36. Americas GP Vaccination Sales by Country (2017-2022) & (K Units)

Table 37. Americas GP Vaccination Sales Market Share by Country (2017-2022)

Table 38. Americas GP Vaccination Revenue by Country (2017-2022) & ($ Millions)

Table 39. Americas GP Vaccination Revenue Market Share by Country (2017-2022)

Table 40. Americas GP Vaccination Sales by Type (2017-2022) & (K Units)

Table 41. Americas GP Vaccination Sales Market Share by Type (2017-2022)

Table 42. Americas GP Vaccination Sales by Application (2017-2022) & (K Units)

Table 43. Americas GP Vaccination Sales Market Share by Application (2017-2022)

Table 44. APAC GP Vaccination Sales by Region (2017-2022) & (K Units)

Table 45. APAC GP Vaccination Sales Market Share by Region (2017-2022)

Table 46. APAC GP Vaccination Revenue by Region (2017-2022) & ($ Millions)

Table 47. APAC GP Vaccination Revenue Market Share by Region (2017-2022)

Table 48. APAC GP Vaccination Sales by Type (2017-2022) & (K Units)

Table 49. APAC GP Vaccination Sales Market Share by Type (2017-2022)

Table 50. APAC GP Vaccination Sales by Application (2017-2022) & (K Units)

Table 51. APAC GP Vaccination Sales Market Share by Application (2017-2022)

Table 52. Europe GP Vaccination Sales by Country (2017-2022) & (K Units)

Table 53. Europe GP Vaccination Sales Market Share by Country (2017-2022)

Table 54. Europe GP Vaccination Revenue by Country (2017-2022) & ($ Millions)

Table 55. Europe GP Vaccination Revenue Market Share by Country (2017-2022)

Table 56. Europe GP Vaccination Sales by Type (2017-2022) & (K Units)

Table 57. Europe GP Vaccination Sales Market Share by Type (2017-2022)

Table 58. Europe GP Vaccination Sales by Application (2017-2022) & (K Units)

Table 59. Europe GP Vaccination Sales Market Share by Application (2017-2022)

Table 60. Middle East & Africa GP Vaccination Sales by Country (2017-2022) & (K Units)

Table 61. Middle East & Africa GP Vaccination Sales Market Share by Country (2017-2022)

Table 62. Middle East & Africa GP Vaccination Revenue by Country (2017-2022) & ($ Millions)

Table 63. Middle East & Africa GP Vaccination Revenue Market Share by Country (2017-2022)

Table 64. Middle East & Africa GP Vaccination Sales by Type (2017-2022) & (K Units)

Table 65. Middle East & Africa GP Vaccination Sales Market Share by Type (2017-2022)

Table 66. Middle East & Africa GP Vaccination Sales by Application (2017-2022) & (K Units)

Table 67. Middle East & Africa GP Vaccination Sales Market Share by Application (2017-2022)

Table 68. Key Market Drivers & Growth Opportunities of GP Vaccination

Table 69. Key Market Challenges & Risks of GP Vaccination

Table 70. Key Industry Trends of GP Vaccination

Table 71. GP Vaccination Raw Material

Table 72. Key Suppliers of Raw Materials

Table 73. GP Vaccination Distributors List

Table 74. GP Vaccination Customer List

Table 75. Global GP Vaccination Sales Forecast by Region (2023-2028) & (K Units)

Table 76. Global GP Vaccination Sales Market Forecast by Region

Table 77. Global GP Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)

Table 78. Global GP Vaccination Revenue Market Share Forecast by Region (2023-2028)

Table 79. Americas GP Vaccination Sales Forecast by Country (2023-2028) & (K Units)

Table 80. Americas GP Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)

Table 81. APAC GP Vaccination Sales Forecast by Region (2023-2028) & (K Units)

Table 82. APAC GP Vaccination Revenue Forecast by Region (2023-2028) & ($ millions)

Table 83. Europe GP Vaccination Sales Forecast by Country (2023-2028) & (K Units)

Table 84. Europe GP Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)

Table 85. Middle East & Africa GP Vaccination Sales Forecast by Country (2023-2028) & (K Units)

Table 86. Middle East & Africa GP Vaccination Revenue Forecast by Country (2023-2028) & ($ millions)

Table 87. Global GP Vaccination Sales Forecast by Type (2023-2028) & (K Units)

Table 88. Global GP Vaccination Sales Market Share Forecast by Type (2023-2028)

Table 89. Global GP Vaccination Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 90. Global GP Vaccination Revenue Market Share Forecast by Type (2023-2028)

Table 91. Global GP Vaccination Sales Forecast by Application (2023-2028) & (K Units)

Table 92. Global GP Vaccination Sales Market Share Forecast by Application (2023-2028)

Table 93. Global GP Vaccination Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 94. Global GP Vaccination Revenue Market Share Forecast by Application (2023-2028)

Table 95. Moderna Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 96. Moderna GP Vaccination Product Offered

Table 97. Moderna GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 98. Moderna Main Business

Table 99. Moderna Latest Developments

Table 100. CanSino Biologicals Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 101. CanSino Biologicals GP Vaccination Product Offered

Table 102. CanSino Biologicals GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 103. CanSino Biologicals Main Business

Table 104. CanSino Biologicals Latest Developments

Table 105. Inovio Pharmaceuticals Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 106. Inovio Pharmaceuticals GP Vaccination Product Offered

Table 107. Inovio Pharmaceuticals GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 108. Inovio Pharmaceuticals Main Business

Table 109. Inovio Pharmaceuticals Latest Developments

Table 110. Shenzhen Geno-Immune Medical Institute Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 111. Shenzhen Geno-Immune Medical Institute GP Vaccination Product Offered

Table 112. Shenzhen Geno-Immune Medical Institute GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 113. Shenzhen Geno-Immune Medical Institute Main Business

Table 114. Shenzhen Geno-Immune Medical Institute Latest Developments

Table 115. GlaxoSmithKine Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 116. GlaxoSmithKine GP Vaccination Product Offered

Table 117. GlaxoSmithKine GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 118. GlaxoSmithKine Main Business

Table 119. GlaxoSmithKine Latest Developments

Table 120. Pfizer Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 121. Pfizer GP Vaccination Product Offered

Table 122. Pfizer GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 123. Pfizer Main Business

Table 124. Pfizer Latest Developments

Table 125. Johnson&Johnson Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 126. Johnson&Johnson GP Vaccination Product Offered

Table 127. Johnson&Johnson GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 128. Johnson&Johnson Main Business

Table 129. Johnson&Johnson Latest Developments

Table 130. Heat Biologics Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 131. Heat Biologics GP Vaccination Product Offered

Table 132. Heat Biologics GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 133. Heat Biologics Main Business

Table 134. Heat Biologics Latest Developments

Table 135. Sanofi Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 136. Sanofi GP Vaccination Product Offered

Table 137. Sanofi GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 138. Sanofi Main Business

Table 139. Sanofi Latest Developments

Table 140. Takis Biotech Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 141. Takis Biotech GP Vaccination Product Offered

Table 142. Takis Biotech GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 143. Takis Biotech Main Business

Table 144. Takis Biotech Latest Developments

Table 145. Zydus Cadila Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 146. Zydus Cadila GP Vaccination Product Offered

Table 147. Zydus Cadila GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 148. Zydus Cadila Main Business

Table 149. Zydus Cadila Latest Developments

Table 150. Codagenix Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 151. Codagenix GP Vaccination Product Offered

Table 152. Codagenix GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 153. Codagenix Main Business

Table 154. Codagenix Latest Developments

Table 155. GeoVax Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 156. GeoVax GP Vaccination Product Offered

Table 157. GeoVax GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 158. GeoVax Main Business

Table 159. GeoVax Latest Developments

Table 160. Bravovax Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 161. Bravovax GP Vaccination Product Offered

Table 162. Bravovax GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 163. Bravovax Main Business

Table 164. Bravovax Latest Developments

Table 165. Altimmune Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 166. Altimmune GP Vaccination Product Offered

Table 167. Altimmune GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 168. Altimmune Main Business

Table 169. Altimmune Latest Developments

Table 170. Vaxart Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 171. Vaxart GP Vaccination Product Offered

Table 172. Vaxart GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 173. Vaxart Main Business

Table 174. Vaxart Latest Developments

Table 175. Clover Biopharmaceuticals Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 176. Clover Biopharmaceuticals GP Vaccination Product Offered

Table 177. Clover Biopharmaceuticals GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 178. Clover Biopharmaceuticals Main Business

Table 179. Clover Biopharmaceuticals Latest Developments

Table 180. ImmunoPrecise Basic Information, GP Vaccination Manufacturing Base, Sales Area and Its Competitors

Table 181. ImmunoPrecise GP Vaccination Product Offered

Table 182. ImmunoPrecise GP Vaccination Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2020-2022)

Table 183. ImmunoPrecise Main Business

Table 184. ImmunoPrecise Latest Developments

List of Figures

Figure 1. Picture of GP Vaccination

Figure 2. GP Vaccination Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global GP Vaccination Sales Growth Rate 2017-2028 (K Units)

Figure 7. Global GP Vaccination Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. GP Vaccination Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of DNA

Figure 10. Product Picture of Non-replicating Viral Vector

Figure 11. Product Picture of Protein Subunit

Figure 12. Product Picture of RNA

Figure 13. Product Picture of Others

Figure 14. Global GP Vaccination Sales Market Share by Type in 2021

Figure 15. Global GP Vaccination Revenue Market Share by Type (2017-2022)

Figure 16. GP Vaccination Consumed in Adults

Figure 17. Global GP Vaccination Market: Adults (2017-2022) & (K Units)

Figure 18. GP Vaccination Consumed in Children

Figure 19. Global GP Vaccination Market: Children (2017-2022) & (K Units)

Figure 20. Global GP Vaccination Sales Market Share by Application (2017-2022)

Figure 21. Global GP Vaccination Revenue Market Share by Application in 2021

Figure 22. GP Vaccination Revenue Market by Company in 2021 ($ Million)

Figure 23. Global GP Vaccination Revenue Market Share by Company in 2021

Figure 24. Global GP Vaccination Sales Market Share by Geographic Region (2017-2022)

Figure 25. Global GP Vaccination Revenue Market Share by Geographic Region in 2021

Figure 26. Global GP Vaccination Sales Market Share by Region (2017-2022)

Figure 27. Global GP Vaccination Revenue Market Share by Country/Region in 2021

Figure 28. Americas GP Vaccination Sales 2017-2022 (K Units)

Figure 29. Americas GP Vaccination Revenue 2017-2022 ($ Millions)

Figure 30. APAC GP Vaccination Sales 2017-2022 (K Units)

Figure 31. APAC GP Vaccination Revenue 2017-2022 ($ Millions)

Figure 32. Europe GP Vaccination Sales 2017-2022 (K Units)

Figure 33. Europe GP Vaccination Revenue 2017-2022 ($ Millions)

Figure 34. Middle East & Africa GP Vaccination Sales 2017-2022 (K Units)

Figure 35. Middle East & Africa GP Vaccination Revenue 2017-2022 ($ Millions)

Figure 36. Americas GP Vaccination Sales Market Share by Country in 2021

Figure 37. Americas GP Vaccination Revenue Market Share by Country in 2021

Figure 38. United States GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 39. Canada GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 40. Mexico GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 41. Brazil GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 42. APAC GP Vaccination Sales Market Share by Region in 2021

Figure 43. APAC GP Vaccination Revenue Market Share by Regions in 2021

Figure 44. China GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 45. Japan GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 46. South Korea GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 47. Southeast Asia GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 48. India GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 49. Australia GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 50. Europe GP Vaccination Sales Market Share by Country in 2021

Figure 51. Europe GP Vaccination Revenue Market Share by Country in 2021

Figure 52. Germany GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 53. France GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 54. UK GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 55. Italy GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 56. Russia GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 57. Middle East & Africa GP Vaccination Sales Market Share by Country in 2021

Figure 58. Middle East & Africa GP Vaccination Revenue Market Share by Country in 2021

Figure 59. Egypt GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 60. South Africa GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 61. Israel GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 62. Turkey GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 63. GCC Country GP Vaccination Revenue Growth 2017-2022 ($ Millions)

Figure 64. Manufacturing Cost Structure Analysis of GP Vaccination in 2021

Figure 65. Manufacturing Process Analysis of GP Vaccination

Figure 66. Industry Chain Structure of GP Vaccination

Figure 67. Channels of Distribution

Figure 68. Distributors Profiles

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025

The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...

  • Publish Date: June 24, 2019
  • $1050
Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts

The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...

  • Publish Date: February 18, 2019
  • $1290
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...

  • Publish Date: December 11, 2018
  • $1390